An enterovirus vaccine developed in Taiwan has proved highly successful in the animal testing stage and is set to proceed to human clinical trials, a researcher at the National Health Research Institutes (NHRI) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open lower
04/19/2024 09:09 AM - Politics
MOFA warns against trusting documents sold on dark web
04/18/2024 10:05 PM - Politics
Taiwan eyes 50% female representation in parliament: VP-elect
04/18/2024 09:51 PM - Politics
Taiwan upgrades satellite network system on Taiping Island
04/18/2024 09:22 PM - Business
Cabinet passes draft amendment to extend tax incentives for SMEs
04/18/2024 09:21 PM